This IPI panel discussed the compatibility and potential synergies between the global drug control regime and the advancement of SDGs, ahead of the 2016 UNGASS on drugs.
This analysis describes a pilot project to engage with drug users in police custody in OST. It demonstrates the benefits of a humane approaches to drug users as opposed to punitive measures.
Most of the developing world has very restricted access to pain-relief medication, partially due to restrictions on listed substances, and the upcoming UNGASS can be a chance to close this gap.
The Harm Reduction conference in Malaysia raises the question what the decisive factors in making the upcoming UNGASS successful will be, and whether Ban Ki-Moon will step up to bring about change.
An open letter signed by 33 groups warns the Global Fund for AIDS, Tuberculosis and Malaria of the effects of its funding withdrawal on middle-income countries and recommends establishing a transition strategy.
The Thai Office of Narcotics Control Board admitted that criminalisation has not solved the drug consumption and trafficking problems, and that there are alternative ways to help strengthen communities.
A variety of harm reduction programmes were presented at the international conference in Kuala Lumpur, Malaysia, and resulting documents are now accessible online.
The Drug Policy Alliance’s Office of Academic Engagement announces Robin Room as the recipient of its annual Alfred R. Lindesmith Award for Achievement in the Field of Scholarship.
Criminalising people who use drugs doesn't work, and it harms our society. HCLU congratulates the UN drug agency for having prepared a paper which supports decriminalisation – and encourages the agency to endorse their own report.
The fact that Colombia’s decriminalization law and apparent progressiveness from the current government has not translated into on-the-ground implementation raises questions of how the cultural shift away from criminal justice solutions to the issue can begin.
The International HIV/AIDS Alliance invites you to register for a 6-months course on harm reduction, particularly focused on HIV and hepatitis C prevention.